| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $492.5M | +5.4% |
| Cost of Revenue | $74.1M | -6.9% |
| Gross Profit | $418.4M | +7.9% |
| R&D Expense | $126.9M | -10.3% |
| SG&A Expense | $101.6M | -2.6% |
| Operating Income | $5.8M | +109.8% |
| Pre-tax Income | $20.2M | +148.3% |
| Income Tax | -$152.5M | -8655.5% |
| Net Income | $173.4M | +505.7% |
| EPS (Basic) | $1.91 | +423.7% |
| EPS (Diluted) | $1.87 | +416.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.4M | -31.5% |
| Short-term Investments | $232.4M | +3.6% |
| Accounts Receivable | $108.4M | +1.0% |
| Current Assets | $612.2M | -14.0% |
| Total Assets | $990.5M | +6.8% |
| Current Liabilities | $303.9M | -17.7% |
| Long-term Debt | $420.6M | -13.2% |
| Total Liabilities |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $114.9M | -2.6% |
| Capital Expenditures | $2.9M | +5.4% |
| Investing Cash Flow | -$18.3M | +8.5% |
| Financing Cash Flow | -$206.4M | -77.7% |
| Free Cash Flow | $111.9M | -2.8% |
| $719.9M |
| -7.6% |
| Stockholders' Equity | $253.6M | +95.3% |